July 03, 2018
Vicore Pharma and HealthCap create a leading drug development company focused on severe lung diseases
Media
June 29, 2018
FDA APPROVES ZEPHYR ENDOBRONCHIAL VALVE FOR TREATING SEVERE EMPHYSEMA
June 27, 2018
Carisma Therapeutics Announces a $53 Million Series A Financing to Develop Novel CAR Macrophage Cellular Immunotherapy
June 26, 2018
BioClin Therapeutics Appoints Scott Myers as Chairman to its Board of Directors
June 25, 2018
Nordic Nanovector Appoints Eduardo Bravo as Chief Executive Officer
June 22, 2018
Altimmune Restructures Financing Agreement
June 21, 2018
Nordic Nanovector Announces First Patient Dosed in Pivotal PARADIGME Trial of Betalutin® in Third-line Follicular Lymphoma Patients
June 20, 2018
Key Opinion Leaders highlight GS010 efficacy and patient benefits in discussion of findings from Reverse Phase III clincal trial
June 19, 2018
Targovax granted EU Patent for mutant-RAS neoantigen platform 2nd generation product TG02
June 18, 2018
Nexstim Plc SmartFocusTM TMS technology based therapy used across all university hospitals in Finland
